Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Mitsubishi becomes first organization in Japan to become an Illumina CSPro

Illumina : 20 June, 2008  (Company News)
Mitsubishi Chemical Safety Institute, a provider of various analyses, examinations, and services for pharmaceutical companies, public institutions, and chemical companies, is the first organization in Japan to become an Illumina CSPro (certified service provider).
Illumina CSPro is a collaborative service provider partnership dedicated to ensuring the delivery of the highest-quality data available for genetic analysis applications. Mitsubishi Chemical Safety Institute offers its customers whole-genome and targeted-genotyping services using Illumina's Infinium and GoldenGate Assays.

Both assays utilise Illumina's proprietary BeadArray technology to provide customers the ability to perform large-scale interrogation of the human genome, which enables them to cost-effectively fast forward their research and identify genetic variants linked to disease.

“For the last seven years, we have concentrated on the investigation of toxicogenomics and pharmacogenomics, and have consequently acquired an abundance of experience in the development of genomic analysis technologies,' said Masaru Sekijima, PhD, general manager of Advanced Medical Science Research Center, Mitsubishi Chemical Safety Institute. 'As a result of this hard work, we are excited to become the first Illumina CSPro in Japan, making it possible to provide researchers with the level of high-quality genomic data customers have come to expect from Illumina.'

Illumina CSPro participants undergo a rigorous two-phase certification process that includes minimum data generation, data certification, and an on-site audit of the facility and processes.

'Interest in the Illumina CSPro program continues to grow with more than 20 academic and commercial technology providers already certified or in the process of certification. Now that Mitsubishi Chemical Safety Institute is a partner, we are excited to work with them to make it easier for researchers in Japan to access the power of Illumina's genetic analysis technologies,' said Karen Possemato, director of corporate marketing at Illumina.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo